HOSPITALS
According to the World Health Organisation , each year there are 374m new STI infections , which are mostly chlamydia , gonorrhoea , syphilis and trichomoniasis .
says . “ For instance , reimbursement issues can often get in the way , and take health care decisions away from providers and their patients . Now that the tools are in hand , we need to be able to use them properly .” Outside of testing , the focus really should be on other methods of disease prevention , which can only be achieved with adequate counselling .
“ In addition , understanding the specific barriers that members of the LGBTQ + community face and acting to actively remove those barriers is critical .”
Over the next 12 months , Thermo Fisher Scientific is committed to continuing to work on advancing the access to molecular diagnostic tools that help to progress the standard of care in STIs and other infectious diseases .
“ We can do this by improving education and communication about the technologies currently available , so patients know what they can expect and so laboratorians know what sort of services they should be offering ,” says Feenstra . “ On the policy side , we can continue to gather real-world data on these tools and benefits they provide to patient care and outcomes .”
44 November 2023